Back

High risk of heart failure in desmoglein-2 mutation carriers in arrhythmogenic right ventricular dysplasia/cardiomyopathy

19 June 2017 (14:00 - 14:15)
Organised by:
Congress Presentation Part of: Young Investigator Award: Basic and Translational Science Genetics (Basic Science in Arrhythmias) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Alexis Hermida

CHU Amiens, Paris (France)

5 More presentations in this session

Presentation thumbnail
The antiarrhythmic effects of melatonin in different pathological conditions
Doctor T. Egan Benova (Bratislava, SK)
Abstract
Presentation thumbnail
Integration of noninvasive imaging of repolarization and cellular modelling for personalized medicine in primary ventricular fibrillation
Doctor M. Cluitmans (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome
Doctor D. Akdis (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Optogenetic ablation of spiral wave arrhythmias by creating light lesions
Ms I. Feola (Leiden, NL)
Abstract
Presentation thumbnail
Percutaneous partially-insulated epicardial tool allows low defibrillation tresholds and prevents extra-cardiac stimulation
Doctor M. Pesl (Brno, CZ)
Abstract

Access the full session

Session thumbnail
Young Investigator Award: Basic and Translational Science

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

19 June 2017 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources